Clinical Trial Update: Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants [Phase 2]

View source ↗

Summary

Long-term follow-up results from a Phase 2 study of GLPG0634 (filgotinib) in active rheumatoid arthritis, with the trial status shown as completed and results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-06-04